• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

W2O Acquires Arcus Medica to Accelerate and Deepen Scientific and Medical Communications Offering

Share:

October 15, 2019

W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced the acquisition of Arcus Medica. A recognized leader in medical and scientific communications, Arcus brings a deep bench of doctoral-level experts to W2O who specialize in translating complex clinical and scientific data into clear, meaningful content to help brands influence key audiences in today’s evolving healthcare environment.

This acquisition represents a vital move by W2O to disrupt the status quo in medical and scientific communications by creating a fully integrated communications agency that uses proprietary data and analytics to fuel scientific strategy, peer-to-peer medical engagement and patient-centered narration for clients. Given the highly complex and fragmented nature of the healthcare industry, companies and their brands require data-informed insights and clear, compelling storytelling to drive value. W2O and Arcus share a passion for uncovering deep scientific acuities to build best-in-class strategy and deliver high quality communications that resonate.

“Arcus is a trailblazer in the field of medical and scientific communications, consistently following the data to get to the right outcome for its clients. The addition of Arcus to the W2O family significantly enhances our medical and scientific communications expertise and enriches our offering in this key discipline,” said Jim Weiss, W2O founder and CEO. “Together, we will continue to place science at the center of everything we do, supplementing this prowess with unmatched data analytics and insights, robust strategy and creative know-how to ensure we deliver maximum impact to client business, from the bench to the bedside.”

With the integration of Arcus, W2O’s scientific and medical communications team will comprise approximately 40 best-in-class employees, including 16 doctoral level experts. Arcus co-founders Mary Seideman, MD, PhD, Stan Eapen, PharmD, and Jonathan Seideman, PhD, will all serve in leadership roles at W2O arcus, which will be an integral part of W2O’s single profit and loss (P&L) operation. These tenured industry experts, along with their seasoned team of communicators, will work closely with W2O’s scientific strategy team run by Ujwal Pyati, PhD, and other multidisciplinary teams across the company – including data analysts, brand strategists, creatives and media specialists – to drive differentiated communications and meet diverse client objectives.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We founded Arcus on the premise of serving as strategic partners to our clients by providing world-class communications attuned to the unique challenges of the healthcare market. We couldn’t be more excited about our affiliation with W2O, given Jim and his team’s commitment to becoming the best by understanding every client’s business and treating it as its own, delivering the highest quality work and results and applying data analytics to every program it touches,” said Mary Seideman, Partner, W2O arcus. “Our partnership is genuinely symbiotic, and we look forward to working together to achieve something truly great for our dynamic clients and remarkable people.”

Earlier this year, W2O announced its partnership with New York based investment firm New Mountain Capital, enabling the company to support continued growth and accelerated scaling to meet the evolving needs of its clients in an increasingly digital and data-centric world. The partnership will take W2O to the next level of talent, capability, geographic and technology expansion to serve clients better and more expansively than ever while maintaining the independent, entrepreneurial spirit upon which the company was founded.

“At W2O we actively listen to our clients and continually enhance our capabilities based on what they ask for and what we foresee them needing to move their business forward,” Weiss added. “Integrating Arcus’ scientific and medical communications capability into our expansive, multidisciplinary service offering will ensure we are more competitively positioned and favored in the healthcare communications marketplace, ultimately enabling us to meet the changing demands of our clients and provide our people with greater career growth opportunities.”

Source: Yahoo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • When Ehealth Goes Viral: the Strengths and Weaknesses of Health Tech During COVID-19When Ehealth Goes Viral: the Strengths and Weaknesses of Health Tech During COVID-19
  • Hoth Therapeutics and Algorithm Sciences Execute Letter of Intent to MergeHoth Therapeutics and Algorithm Sciences Execute Letter of Intent to Merge
  • Less Than 10% of Suicide Prevention Apps Cover all the Recommended Strategies: NTU SingaporeLess Than 10% of Suicide Prevention Apps Cover all the Recommended Strategies: NTU Singapore
  • 10 Ways Health Execs Can Improve Organizational Productivity10 Ways Health Execs Can Improve Organizational Productivity
  • Philips, Humana Partner on 2 Pilot Programs to Improve Care for At-Risk Medicare Advantage MembersPhilips, Humana Partner on 2 Pilot Programs to Improve Care for At-Risk Medicare Advantage Members
  • Talkspace Nabs $50M to Broaden Telebehavioral Well being PlatformTalkspace Nabs $50M to Broaden Telebehavioral Well being Platform
  • CMS Launches $1.65M Artificial Intelligence Health Outcomes ChallengeCMS Launches $1.65M Artificial Intelligence Health Outcomes Challenge
  • Can Artificial Intelligence Take the Next Step for Drug Repositioning?Can Artificial Intelligence Take the Next Step for Drug Repositioning?

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications